USD 24.89
(-2.16%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 263 Million USD | 17.94% |
2022 | 223 Million USD | -57.44% |
2021 | 524 Million USD | 16.96% |
2020 | 448 Million USD | -25.33% |
2019 | 600 Million USD | -9.5% |
2018 | 663 Million USD | -13.56% |
2017 | 767 Million USD | -2.17% |
2016 | 784 Million USD | 91.22% |
2015 | 410 Million USD | -18.16% |
2014 | 501 Million USD | -9.89% |
2013 | 556 Million USD | -23.73% |
2012 | 729 Million USD | 25.26% |
2011 | 582 Million USD | -5.37% |
2010 | 615 Million USD | 30.3% |
2009 | 472 Million USD | 25.2% |
2008 | 377 Million USD | 19.3% |
2007 | 316 Million USD | -57.58% |
2006 | 745 Million USD | 123.72% |
2005 | 333 Million USD | 14.82% |
2004 | 290.01 Million USD | 9.66% |
2003 | 264.46 Million USD | 43.15% |
2002 | 184.74 Million USD | -2.11% |
2001 | 188.72 Million USD | -39.11% |
2000 | 309.92 Million USD | 82.81% |
1999 | 169.53 Million USD | 9.0% |
1998 | 155.53 Million USD | -17.25% |
1997 | 187.95 Million USD | -9.07% |
1996 | 206.69 Million USD | 18.59% |
1995 | 174.3 Million USD | 306.84% |
1994 | -84.26 Million USD | -152.41% |
1993 | 160.78 Million USD | 3.13% |
1992 | 155.91 Million USD | 108.83% |
1991 | 74.66 Million USD | -47.84% |
1990 | 143.12 Million USD | -3.05% |
1989 | 147.62 Million USD | 1.65% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 214 Million USD | 0.0% |
2023 Q2 | 172 Million USD | 0.0% |
2023 Q4 | 90.27 Million USD | 0.0% |
2023 FY | 263 Million USD | 17.94% |
2022 Q2 | 177 Million USD | 0.0% |
2022 FY | 223 Million USD | -57.44% |
2022 Q4 | 48.25 Million USD | 0.0% |
2021 Q2 | 205 Million USD | 0.0% |
2021 FY | 524 Million USD | 16.96% |
2021 Q4 | 321.96 Million USD | 0.0% |
2020 Q4 | 341.76 Million USD | 0.0% |
2020 FY | 448 Million USD | -25.33% |
2020 Q2 | 100 Million USD | 0.0% |
2019 Q2 | 309 Million USD | 0.0% |
2019 Q4 | 294.91 Million USD | 0.0% |
2019 FY | 600 Million USD | -9.5% |
2018 Q2 | 274 Million USD | 0.0% |
2018 FY | 663 Million USD | -13.56% |
2018 Q4 | 389 Million USD | 0.0% |
2017 FY | 767 Million USD | -2.17% |
2017 Q2 | 324 Million USD | 0.0% |
2017 Q4 | 443 Million USD | 0.0% |
2016 Q4 | 543 Million USD | 0.0% |
2016 Q2 | 241 Million USD | 0.0% |
2016 FY | 784 Million USD | 91.22% |
2015 FY | 410 Million USD | -18.16% |
2015 Q4 | 115 Million USD | 0.0% |
2015 Q2 | 295 Million USD | 0.0% |
2014 Q2 | 239 Million USD | 0.0% |
2014 Q4 | 262 Million USD | 0.0% |
2014 FY | 501 Million USD | -9.89% |
2013 Q2 | 272 Million USD | 0.0% |
2013 FY | 556 Million USD | -23.73% |
2013 Q4 | 284 Million USD | 0.0% |
2012 Q1 | 161 Million USD | 15.0% |
2012 Q4 | 142 Million USD | 5.97% |
2012 Q2 | 292 Million USD | 81.37% |
2012 Q3 | 134 Million USD | -54.11% |
2012 FY | 729 Million USD | 25.26% |
2011 Q2 | 153 Million USD | -1.92% |
2011 FY | 582 Million USD | -5.37% |
2011 Q4 | 140 Million USD | 5.26% |
2011 Q3 | 133 Million USD | -13.07% |
2011 Q1 | 156 Million USD | -14.29% |
2010 FY | 615 Million USD | 30.3% |
2010 Q4 | 182 Million USD | 32.85% |
2010 Q3 | 137 Million USD | 0.0% |
2010 Q2 | 137 Million USD | -13.84% |
2010 Q1 | 159 Million USD | 24.22% |
2009 Q3 | 128 Million USD | 8.47% |
2009 Q2 | 118 Million USD | 20.41% |
2009 Q1 | 98 Million USD | -16.24% |
2009 Q4 | 128 Million USD | 0.0% |
2009 FY | 472 Million USD | 25.2% |
2008 Q4 | 117 Million USD | 58.11% |
2008 Q2 | 103 Million USD | 24.1% |
2008 Q3 | 74 Million USD | -28.16% |
2008 Q1 | 83 Million USD | -11.7% |
2008 FY | 377 Million USD | 19.3% |
2007 Q2 | 103 Million USD | 13.19% |
2007 Q1 | 91 Million USD | -35.0% |
2007 Q3 | 28 Million USD | -72.82% |
2007 Q4 | 94 Million USD | 235.71% |
2007 FY | 316 Million USD | -57.58% |
2006 Q2 | 96 Million USD | -76.98% |
2006 FY | 745 Million USD | 123.72% |
2006 Q4 | 140 Million USD | 52.17% |
2006 Q3 | 92 Million USD | -4.17% |
2006 Q1 | 417 Million USD | 874.13% |
2005 Q1 | 93 Million USD | 1702.0% |
2005 Q3 | 61.18 Million USD | -35.46% |
2005 Q4 | -53.86 Million USD | -188.04% |
2005 Q2 | 94.8 Million USD | 1.94% |
2005 FY | 333 Million USD | 14.82% |
2004 Q3 | 74.84 Million USD | -1.73% |
2004 FY | 290.01 Million USD | 9.66% |
2004 Q4 | -5.8 Million USD | -107.76% |
2004 Q1 | 73.72 Million USD | -45.17% |
2004 Q2 | 76.16 Million USD | 3.31% |
2003 Q3 | 60.47 Million USD | -12.74% |
2003 Q1 | 42.9 Million USD | -20.61% |
2003 Q4 | 134.45 Million USD | 122.34% |
2003 FY | 264.46 Million USD | 43.15% |
2003 Q2 | 69.3 Million USD | 61.51% |
2002 FY | 184.74 Million USD | -2.11% |
2002 Q2 | 43.5 Million USD | 20.64% |
2002 Q3 | 49.11 Million USD | 12.9% |
2002 Q4 | 54.04 Million USD | 10.04% |
2002 Q1 | 36.06 Million USD | 6.24% |
2001 Q4 | 33.94 Million USD | -28.86% |
2001 Q1 | 51.52 Million USD | 103.47% |
2001 FY | 188.72 Million USD | -39.11% |
2001 Q3 | 47.71 Million USD | -25.88% |
2001 Q2 | 64.37 Million USD | 24.94% |
2000 Q2 | 99.96 Million USD | -11.76% |
2000 FY | 309.92 Million USD | 82.81% |
2000 Q3 | 843.88 Million USD | 744.17% |
2000 Q1 | 113.29 Million USD | 758.65% |
2000 Q4 | -1.48 Billion USD | -275.7% |
1999 Q2 | 57.6 Million USD | -2.04% |
1999 Q1 | 58.8 Million USD | 0.0% |
1999 FY | 169.53 Million USD | 9.0% |
1999 Q4 | -17.2 Million USD | -124.04% |
1999 Q3 | 71.53 Million USD | 24.19% |
1998 FY | 155.53 Million USD | -17.25% |
1997 FY | 187.95 Million USD | -9.07% |
1996 FY | 206.69 Million USD | 18.59% |
1995 FY | 174.3 Million USD | 306.84% |
1994 FY | -84.26 Million USD | -152.41% |
1993 FY | 160.78 Million USD | 3.13% |
1992 FY | 155.91 Million USD | 108.83% |
1991 FY | 74.66 Million USD | -47.84% |
1990 FY | 143.12 Million USD | -3.05% |
1989 FY | 147.62 Million USD | 1.65% |
Name | Net Income | Net Income Difference |
---|---|---|
Abbott Laboratories | 5.72 Billion USD | 95.405% |
Allurion Technologies Inc. | -82.3 Million USD | 419.547% |
Artivion, Inc. | -30.69 Million USD | 956.957% |
Avanos Medical, Inc. | -61.8 Million USD | 525.566% |
Butterfly Network, Inc. | -133.69 Million USD | 296.709% |
Butterfly Network, Inc. | -133.69 Million USD | 296.709% |
Bio-Rad Laboratories, Inc. | -637.32 Million USD | 141.266% |
Boston Scientific Corporation | 1.59 Billion USD | 83.49% |
Perspective Therapeutics, Inc. | -14.67 Million USD | 1892.774% |
CONMED Corporation | 64.45 Million USD | -308.011% |
Edwards Lifesciences Corporation | 1.4 Billion USD | 81.246% |
Paragon 28, Inc. | -47.84 Million USD | 649.738% |
Glaukos Corporation | -134.66 Million USD | 295.305% |
Globus Medical, Inc. | 122.87 Million USD | -114.042% |
Inspire Medical Systems, Inc. | -21.15 Million USD | 1343.322% |
Integer Holdings Corporation | 90.65 Million USD | -190.127% |
Medtronic plc | 3.67 Billion USD | 92.845% |
Nevro Corp. | -92.21 Million USD | 385.209% |
Owlet, Inc. | -32.9 Million USD | 899.368% |
Penumbra, Inc. | 90.95 Million USD | -189.157% |
Vicarious Surgical Inc. | -71.07 Million USD | 470.052% |
Sonendo, Inc. | -60.91 Million USD | 531.721% |
STERIS plc | 378.23 Million USD | 30.467% |
Stryker Corporation | 3.16 Billion USD | 91.69% |
Vapotherm, Inc. | -58.19 Million USD | 551.944% |
Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 74.316% |